Compare CHH & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHH | NVST |
|---|---|---|
| Founded | 1939 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.0B |
| IPO Year | 1997 | 2019 |
| Metric | CHH | NVST |
|---|---|---|
| Price | $107.98 | $29.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $112.42 | $23.85 |
| AVG Volume (30 Days) | 750.5K | ★ 3.5M |
| Earning Date | 02-19-2026 | 02-05-2026 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | ★ 56.73 | N/A |
| EPS | ★ 8.11 | 0.28 |
| Revenue | $819,632,000.00 | ★ $2,719,500,000.00 |
| Revenue This Year | $101.97 | $2.81 |
| Revenue Next Year | $2.19 | $3.54 |
| P/E Ratio | ★ $13.48 | $104.02 |
| Revenue Growth | N/A | ★ 8.32 |
| 52 Week Low | $84.04 | $14.22 |
| 52 Week High | $157.86 | $29.28 |
| Indicator | CHH | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 58.28 | 80.20 |
| Support Level | $104.96 | $22.75 |
| Resistance Level | $109.67 | $24.48 |
| Average True Range (ATR) | 4.16 | 0.95 |
| MACD | 0.04 | 0.46 |
| Stochastic Oscillator | 77.49 | 99.29 |
At year-end 2024, Choice Hotels operated 654,000 rooms across the economy, midscale, upscale, and extended-stay segments. Comfort Inn and Comfort Suites are the largest brands (26% of the company's total domestic rooms), while Ascend and Cambria (10%) are newer lifestyle and select-service brands. Choice closed on its Radisson acquisition in August 2022, which added about 70,000 rooms. Franchises account for 100% of total revenue, and the United States represented 78% of total rooms in 2024.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.